COVID-19: Don’t let the guard down, caution experts
If caution is thrown to the wind, we could well be laying out an invitation for a second wave, which the country can ill afford. (PTI Photo/File) If there are…
COVID-19 vaccine: Case now to ramp up supplies at lower prices, says expert
Almost all the major platforms to make the vaccines are being carried out in India by at least half a dozen leading Indian vaccine companies and many smaller companies. (AP…
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax: The announcement comes a day after Novovax Inc said that its Covid-19 vaccine Covovax was 89.3% effective…
Deliverance 2021: Indian firms up cold storage & vial supplies as govt readies vaccine roll out
In the space for glass vials needed for the vaccines, companies have been expanding capacities and ramping up supplies. (AP image/Representational picture)Deliverance in the new year will come encased in…
Covid-19 vaccination: Can’t deny chances of an adverse event, states told to be prepared, says health secretary
India's Case Fatality Rate (CFR) is 1.45 per cent, whereas globally it is 2.26 per cent, Bhushan avered, adding that India's CFR is among the lowest in the world. (Representational…
Does COVID-19 vaccine have similar immune response in old and young? Here’s what Moderna’s trials show
Moderna is now reporting interim data from the Phase 1 study, which includes new analysis from 20 additional people and details on how the vaccine performs in older people. (Representational…
Reason behind rise in Covid cases? Coronavirus re-infections raise concerns about immunity
Some experts say it is likely that such cases are starting to emerge because of greater testing worldwide, rather than because the virus may be spreading differently. (Representational image)Two European…
People not wearing masks, maintaining social distancing driving COVID-19 pandemic in India: ICMR DG
The testing for the disease has been increased from 363 tests per million per day on August 1 to more than 600 tests per million per day at present, the…